EcoDrugPlus

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSAMXG00000019558
Gene Symbol: UGCG
3 Cross references
212 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSAMXG00000003848
Gene Symbol: WEE1
3 Cross references
206 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSAMXG00000032321
Gene Symbol: WEE1
2 Cross references
141 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSAMXG00000007250
Gene Symbol: YES1
4 Cross references
146 Possible Orthologues:

Acetylcholinesterase (Cartwright Blood Group)

Ensembl ID : ENSAMXG00000005681
Gene Symbol: ACHE
3 Cross references
234 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSAMXG00000021386
Gene Symbol: ACVR2B
3 Cross references
194 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSAMXG00000032156
Gene Symbol: ACVR2B
3 Cross references
196 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSAMXG00000031102
Gene Symbol: ADORA1
3 Cross references
208 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSAMXG00000033574
Gene Symbol: ADORA2A
4 Cross references
200 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSAMXG00000017327
Gene Symbol: ADA
3 Cross references
219 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSAMXG00000007715
Gene Symbol: LOC103022582
3 Cross references
201 Possible Orthologues:

Adenosine Receptor A1-Like

Ensembl ID : ENSAMXG00000038612
Gene Symbol: LOC103047745
2 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).